Neulasta FIRST STEP®Program Registration
Welcome to the Neulasta FIRST STEP® Program.
Please complete the online form below to register your card.
If you have any questions or problems using your card after registration, please call 1-888-65-STEP1 (1-888-657-8371) from 9 a.m. to 8 p.m. ET, Monday-Friday.
Neulasta® (pegfilgrastim) is prescribed to reduce the risk of infection (initially marked by fever) in patients with some tumors receiving strong chemotherapy that decreases the number of infection-fighting white blood cells.
Important Safety Information
Do not take Neulasta® if you have had an allergic reaction to Neulasta® (pegfilgrastim) or to NEUPOGEN® (filgrastim). Tell your doctor if you have sickle cell disorder before using Neulasta®. Ruptured spleen (including fatal cases), a serious lung problem called acute respiratory distress syndrome (ARDS), serious allergic reactions, and sickle cell crises can occur. Call your doctor or seek emergency care right away if you have: pain in the left upper stomach area or left shoulder tip pain (symptoms of an enlarged or ruptured spleen); shortness of breath, trouble breathing, or a fast rate of breathing (symptoms of ARDS); shortness of breath, wheezing, dizziness, swelling around the mouth or eyes, fast pulse, sweating, and hives (symptoms of an allergic reaction); or if you have pain or difficulty breathing (symptoms of sickle cell crises). The most common side effect you may experience is aching in the bones and muscles.
If you have any questions about this information, be sure to discuss them with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.
Please click here for full Neulasta® product information.